Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Keratosis, Actinic 3Carcinoma, Basal Cell 3Skin Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Urinary Bladder Neoplasms 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Depression 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

Music Therapy 15Cognitive Behavioral Therapy 13Therapeutics 12Surveys and Questionnaires 12Psychiatric Rehabilitation 9Methods 9Standard of Care 8Psilocybin 7Educational Status 7Mindfulness 6Hypnosis 6Early Intervention, Educational 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Control Groups 5Art Therapy 5Aromatherapy 5Saline Solution 4Ketamine 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Behavior Therapy 4Autogenic Training 4Acupuncture Therapy 4Yoga 3Weights and Measures 3Touch 3Therapeutic Touch 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anxiety Disorders × Niacinamide × Clear all
NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡